A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (Q63574274)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis |
clinical trial |
Statements
LUCENT 2 (English)
0 references
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2) (English)
0 references
19 October 2018
0 references
15 June 2021
0 references
1,044
0 references
18 year
0 references
80 year
0 references